Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Plasma L-dopa in the diagnosis of patients with melanoma

Conference · · J. Nucl. Med.; (United States)
OSTI ID:6861984
Melanoma is one of a group of neoplasms that is characterized biochemically by abnormal tyrosine metabolism. The main objective of this paper is to establish whether or not the measurement of plasma L-dopa represents a specific indicator for the biochemical diagnosis of melanoma. Two groups of patients were studied: group 1 consisted of 20 patients with stage 2 and 3 disseminated melanoma, and group 2 consisted of 20 patients with non-malignant melanoma. L-dopa in plasma was measured by a radio-enzymatic technique. The method was based upon the incubation (37/sup 0/C, 40 min) of 50 ..mu..l of plasma in the presence of catechol-O-methyltransferase, dopa decarboxylase and S-(3H)-adenosylmethionine (5 ..mu..Ci, sp. act. ci/mmol). The formed methylated decarboxylated metabolite 3H-3-0-methyldopamine was characterized by radiochromatographic analysis. The results of the study showed that plasma L-dopa was elevated significantly in patients with disseminated melanoma (av 4.9 ng/ml) as compared with non-malignant melanoma patients (av 0.9 ng/ml) and control subjects. The measurement of plasm L-dopa represents a specific marker for detection of metastatic melanoma.
Research Organization:
Dept. of Radiology (Div. Nuc. Med.), Emory Univ. School of Medicine, Atlanta, GA
OSTI ID:
6861984
Report Number(s):
CONF-840619-
Conference Information:
Journal Name: J. Nucl. Med.; (United States) Journal Volume: 25:5
Country of Publication:
United States
Language:
English